262 related articles for article (PubMed ID: 36449419)
1. Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.
Suarez EA; Huybrechts KF; Straub L; Hernández-Díaz S; Jones HE; Connery HS; Davis JM; Gray KJ; Lester B; Terplan M; Mogun H; Bateman BT
N Engl J Med; 2022 Dec; 387(22):2033-2044. PubMed ID: 36449419
[TBL] [Abstract][Full Text] [Related]
2. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
[TBL] [Abstract][Full Text] [Related]
3. Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
Wang S; Meador KJ; Pawasauskas J; Lewkowitz AK; Ward KE; Brothers TN; Hartzema A; Quilliam BJ; Wen X
Drug Saf; 2023 Mar; 46(3):257-271. PubMed ID: 36642778
[TBL] [Abstract][Full Text] [Related]
4. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
[TBL] [Abstract][Full Text] [Related]
5. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
[TBL] [Abstract][Full Text] [Related]
6. Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV; Katz E; Weitz B; Visconti K
Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
[TBL] [Abstract][Full Text] [Related]
7. Opioid Use Disorder and Perinatal Outcomes.
Piske M; Homayra F; Min JE; Zhou H; Marchand C; Mead A; Ng J; Woolner M; Nosyk B
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34479983
[TBL] [Abstract][Full Text] [Related]
8. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.
Brogly SB; Saia KA; Walley AY; Du HM; Sebastiani P
Am J Epidemiol; 2014 Oct; 180(7):673-86. PubMed ID: 25150272
[TBL] [Abstract][Full Text] [Related]
9. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
10. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
13. Comparison of buprenorphine and methadone in the management of maternal opioid use disorder in full term pregnancies.
Staszewski CL; Garretto D; Garry ET; Ly V; Davis JA; Herrera KM
J Perinat Med; 2020 Sep; 48(7):677-680. PubMed ID: 32681781
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
Lacroix I; Berrebi A; Garipuy D; Schmitt L; Hammou Y; Chaumerliac C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
Eur J Clin Pharmacol; 2011 Oct; 67(10):1053-9. PubMed ID: 21538146
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine and naloxone compared with methadone treatment in pregnancy.
Wiegand SL; Stringer EM; Stuebe AM; Jones H; Seashore C; Thorp J
Obstet Gynecol; 2015 Feb; 125(2):363-368. PubMed ID: 25569005
[TBL] [Abstract][Full Text] [Related]
16. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
Zedler BK; Mann AL; Kim MM; Amick HR; Joyce AR; Murrelle EL; Jones HE
Addiction; 2016 Dec; 111(12):2115-2128. PubMed ID: 27223595
[TBL] [Abstract][Full Text] [Related]
18. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study.
Serra AE; Lemon LS; Mokhtari NB; Parks WT; Catov JM; Venkataramanan R; Caritis SN
Am J Obstet Gynecol; 2017 Apr; 216(4):418.e1-418.e5. PubMed ID: 28024988
[TBL] [Abstract][Full Text] [Related]
19. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
[TBL] [Abstract][Full Text] [Related]
20. The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.
Lemon LS; Naimi A; Caritis SN; Platt RW; Venkataramanan R; Bodnar LM
Paediatr Perinat Epidemiol; 2018 Mar; 32(2):213-222. PubMed ID: 29372750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]